Nifty Midcap 100 59597.8 (-0.20)
Nifty Pharma 22562.3 (-0.47)
Nifty 50 25732.3 (-0.22)
SENSEX 83627.69 (-0.30)
Nifty Bank 59578.8 (0.22)
Nifty IT 38236.55 (0.65)
Nifty Next 50 68522 (-0.26)
Nifty Smallcap 100 17295.8 (0.60)
NIKKEI 225 53549.16 (3.10)
HANG SENG 26848.47 (0.90)
S&P 6978.43 (-0.28)
13-Feb-2025
PAT of continuing business down 11% on lower sales
'Net sales (including other operating income) of WPIL for the quarter ended Dec 2024 has declined 11.40% to Rs 381.6 crore. Operating profit margin has declined from 16.24% to 12.61%, leading to 31.21% decline in operating profit to Rs 48.11 crore. Raw material cost as a % of total sales (net of stock adjustments) increased from 17.72% to 27.71%. Employee cost increased from 13.75% to 15.14%. Other expenses fell from 51.31% to 44.85%. Contract job process charges fell from 40.14% to 31.50%. Other income rose 23.33% to Rs 11.1 crore. PBIDT fell 24.99% to Rs 59.21 crore. Provision for interest rose 19.61% to Rs 11.16 crore. PBDT fell 30.97% to Rs 48.05 crore. Provision for depreciation rose 8.74% to Rs 8.34 crore. Profit before tax down 35.89% to Rs 39.71 crore. Share of profit/loss was 144.63% higher at Rs 5.92 crore. Provision for tax was expense of Rs 8.5...
(13-Jan-2026)
Net profit jumps 20%, VNB improves in Q3FY2026
Net up 33% on strong operating show
Revenue up 13.3% YoY to Rs 33872 crore in Q3FY2026
Revenue up 4.9% YoY to Rs 67087 crore in Q3FY2026
Analyst Meet / AGM-Conference Call (25-Nov-2025)
International projects margins have started improving and are expected to normalize
Results-Analysis (20-Aug-2025)
Net down 42% as OPM stay low
Analyst Meet / AGM-Conference Call (06-Aug-2025)
Optimistic about H2FY26
Results-Analysis (23-May-2025)
Net down 98% on weak operating show